VITEK® 2 Compact 30, REF numbers: 27530 and 27530R (clinical), and 27630 and 17630R (industry) software and reagent cards designed for the identification (ID) and antimicrobial susceptibility testing (AST) of bacteria and yeast.
Published September 6, 2017 · Recall initiated: July 12, 2017
Summary
FDA records medical device Class II recall Z-3076-2017, published September 6, 2017 and initiated July 12, 2017. Recalling firm: Biomerieux Inc; Status: Terminated; Reported quantity: 9234 units; Lot: VITEK® 2 Compact 15 and Compact 30 instruments previously manufactured/installed with VITEK® 2 System software versions prior to 5.01, and currently being upgraded to version 8.01. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Customers have reported that some VITEK® 2 cards are staying in preliminary status, not finalizing after ejection from the instrument, and not allowing cards in subsequent carousel slots to be processed. The issue was reported to occur on VITEK® 2 Compact 15 and Compact 30 systems following a system software update to version 8.01.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Biomerieux Inc
- Distributor
- Worldwide
- Lot
- VITEK® 2 Compact 15 and Compact 30 instruments previously manufactured/installed with VITEK® 2 System software versions prior to 5.01, and currently being upgraded to version 8.01.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAVITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811September 30, 2026
- FDAVITEK 2 AST-N447 TEST KIT Product reference 424620July 15, 2026
- FDAVITEK 2 Gram-negative Susceptibility Cards Containing o Polymyxin B (pb02n) o Ceftazidime/avibactam (cza02n) oFebruary 11, 2026
- FDAVITEK 2 - AST Test kits (in vitro diagnostic test cards for antimicrobial susceptibility): a) AST-N334, REFMay 1, 2024
- FDAVITEK® 2 Compact 15, REF numbers: 27415 and 27415R software and reagent cards designed for the identificationSeptember 6, 2017
- FDAFogarty Adherent Clot Catheter Model Numbers 1408010 and 140806 Product Usage: The Fogarty adherent clotSeptember 6, 2017
Questions about this recall
Was VITEK® 2 Compact 30, REF numbers: 27530 and 27530R (clinical), and 27630 and 17630R (industry) software and reagent cards designed for the identification (ID) and antimicrobial susceptibility testing (AST) of bacteria and yeast. recalled?
Yes. FDA published recall Z-3076-2017 on September 6, 2017. Reported hazard: Customers have reported that some VITEK® 2 cards are staying in preliminary status, not finalizing after ejection from the instrument, and not allowing cards in subsequent carousel slots to be processed. The issue was reported to occur on VITEK® 2 Compact 15 and Compact 30 systems following a system software update to version 8.01.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail